ABT — ABBOTT LABORATORIES
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1800 ·
Last close
$110.91
Market Cap
$193.18B
52W High
$111.28
52W Low
$82.10
ADV30
11,284,439
Next earnings
2026-10-14
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 11,164,000,000 | 6,274,000,000 | 1,345,000,000 | 1,077,000,000 | 110,429,000,000 | 6,803,000,000 | 57,728,000,000 |
| Dec 2025 | 11,459,000,000 | 6,537,000,000 | 2,251,000,000 | 1,776,000,000 | 86,713,000,000 | 8,522,000,000 | 33,942,000,000 |
| Sep 2025 | 11,369,000,000 | 6,294,000,000 | 2,057,000,000 | 1,644,000,000 | 84,181,000,000 | 7,511,000,000 | 32,917,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$9,464,000,000
Investing CF
$-22,276,000,000
Financing CF
$13,059,000,000
CapEx
$-2,086,000,000
Dividends Paid
$-4,188,000,000
Buybacks
$-793,000,000
EPS Diluted TTM
$3.09
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$49,956,000,000
Inventory
$6,989,000,000
Receivables
$11,224,000,000
ST Investments
$492,000,000
EBIT TTM
$8,673,000,000
Pretax Income TTM
$8,137,000,000
Interest Exp TTM
$536,000,000
Analysts
24
Yahoo Snapshot (yfinance, live)
Total Revenue
$46,584,999,936
EBITDA
$11,681,000,448
Free Cash Flow
$7,209,124,864
Enterprise Value
$219,685,814,272
Total Cash
$5,602,999,808
Total Debt
$32,719,998,976
Shares Out
1,741,813,154
Trailing EPS
$3.13
Book Value
$29.54
ROE
10.6%
ROA
5.3%
Div Yield
2.30%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 44,328,000,000 | 8,053,000,000 | 6,524,000,000 | 86,713,000,000 | 33,942,000,000 | — | 9,566,000,000 |
| Dec 2024 | 41,950,000,000 | 6,825,000,000 | 13,402,000,000 | 81,414,000,000 | 33,513,000,000 | — | 8,558,000,000 |
| Dec 2023 | 40,109,000,000 | 6,478,000,000 | 5,723,000,000 | 73,214,000,000 | 34,387,000,000 | — | 7,261,000,000 |
| Dec 2022 | 43,653,000,000 | 8,362,000,000 | 6,933,000,000 | 74,438,000,000 | 37,533,000,000 | — | 9,581,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$6.06
Max Pain — expiry 2026-08-21
max pain strike: $97.50 · spot: $111.03 · call oi: 32,812 · put oi: 17,732
Expected Move to 2026-08-21:
±$3.08
(2.77%) —
implied range
$107.95 –
$114.10
· ATM straddle on $111.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NVO | NOVO NORDISK A S | $153.38B | $46.39 | — |
| AZN | ASTRAZENECA PLC | $245.82B | $158.50 | — |
| PFE | PFIZER INC | $149.96B | $26.31 | — |
| NONOF | NOVO NORDISK A S | $143.36B | $43.36 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $133.17B | $525.73 | — |
News headlines (Yahoo Finance, 1h cache)
What's Backing Abbott's Established Pharmaceuticals Division Growth
2026-08-13 12:49 · Yahoo
Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools
2026-08-12 21:13 · Yahoo
Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis
2026-08-12 13:14 · Yahoo
Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations
2026-08-11 17:41 · Yahoo
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
2026-08-10 20:49 · Yahoo
Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
2026-08-13 12:37 · Yahoo
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
2026-08-13 11:53 · Yahoo
[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Grow
2026-08-12 17:30 · Yahoo
The Advertising Research Foundation Announces 2026 ARF David Ogilvy Awards Finalists
2026-08-13 15:02 · Yahoo
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?
2026-08-12 18:36 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.